Clinical Trials on CYP2D6, Psychiatric Patients in Argentina

Total 16 results

Universidad Nacional de Rosario

Completed

Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward (IM-OK-FAST)

Psychomotor Agitation | Psychiatric Disorder | Emergency Psychiatric | Tranquilizers

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Impact of Email Reminders on No-Show Rates for Appointments in an Urology Department

Reminder Systems | No-Show Patients

Argentina
Fundación Huésped
Pfizer

Unknown

Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients (TERCETO)

AIDS | HIV-1 Adults Patients | Triple Class Failure

Argentina
Hospital Italiano de Buenos Aires

Completed

Temporal Trends in Nonattendence Rate for Scheduled Outpatient Appointments.

Patient Non Attendance to Medical Care

Argentina
Centro de Estudios en Genetica y Reproduccion

Not yet recruiting

Music for Anxiety in Embryo Transfers (MUSIC-ET)

Patient Satisfaction | Test Anxiety | Music | Embryo Transfer | REPRODUCTIVE TECHNIQUES

Argentina
Centro de Estudio de Estado y Sociedad
Dana-Farber Cancer Institute; Deakin University

Completed

Evaluation of a mHealth Intervention to Increase Adherence to Triage of Self-collected HPV+ Women (ATICA Project) (ATICA)

Patient Adherence

Argentina
AstraZeneca

Completed

Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study (LASSYC)

Stable COPD Patients

Mexico, Chile, Argentina, Colombia, Costa Rica, Uruguay
Pfizer

Completed

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (CATS)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
Pfizer
GlaxoSmithKline

Completed

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (EAGLES)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia, Argentina
Latin American Cooperative Oncology Group
GlaxoSmithKline

Completed

Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. (GLICO-0801)

BRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After Taxanes

Argentina, Brazil, Peru
Novartis Pharmaceuticals

Completed

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Obese Patients With Non-alcoholic Steatohepatitis (NASH)

Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada
FibroGen
AstraZeneca; Astellas Pharma Europe B.V.

Completed

Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants (Himalayas)

Anemia in Incident Dialysis Patients

Russian Federation, Bulgaria, Thailand, United States, Argentina, Chile, Colombia, Korea, Republic of, Latvia, Malaysia, Mexico, Poland, Romania, Taiwan, Ukraine
AstraZeneca

Completed

National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups (COMPAR)

Heart Failure | Coronary Patients

France
NYU Langone Health

Recruiting

Natural History Study of Synucleinopathies

Parkinson Disease | Multiple System Atrophy | Neurogenic Orthostatic Hypotension | REM Sleep Behavior Disorder | Pure Autonomic Failure | Dementia With Lewy Bodies | Patients With Synucleinopathies | Shy-Drager Disease

Korea, Republic of, United States, Argentina, Spain
AstraZeneca

Completed

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease (RISE)

COPD Patients

United States, Spain, Bulgaria, Mexico, Poland, South Africa, Germany, Argentina, Chile, Czechia, Puerto Rico
AstraZeneca

Completed

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients (Sweapea)

Asthma Patients

United States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil

Clinical Trials on CYP2D6, Psychiatric Patients in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations